Discontinued — last reported Q4 '25

Equity

Unrealized Gains on Investments

Biogen Unrealized Gains on Investments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 4 years (FY 2020 to FY 2025), Unrealized Gains on Investments shows a downward trend with a -45.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ3 2018
Last reportedQ4 2025

How to read this metric

An increase indicates favorable market conditions for the company's investment portfolio, enhancing the overall book value of the firm.

Detailed definition

This represents the positive difference between the current market value and the amortized cost of available-for-sale in...

Peer comparison

Reflects market-wide interest rate and credit spread environments; comparable across all firms with large investment portfolios.

Metric ID: unrealized_gains_on_investments

Historical Data

13 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q4 '23Q3 '25Q4 '25Q1 '26
Value$1.40M$1.10M$0.00$1.40M$400.00K$100.00K$138.00M$2.30M$1.10M$35.50M$0.00$200.00K$0.00
QoQ Change-21.4%-100.0%-71.4%-75.0%>999%-98.3%-52.2%>999%-100.0%-100.0%
YoY Change-71.4%-90.9%+64.3%+175.0%-74.3%
Range$0.00$138.00M
CAGR-100.0%
Avg YoY Growth+0.5%
Median YoY Growth-71.4%

Unrealized Gains on Investments at Other Companies

Frequently Asked Questions

What is Biogen's unrealized gains on investments?
Biogen (BIIB) reported unrealized gains on investments of $0.00 in Q1 2026.
What is the long-term trend for Biogen's unrealized gains on investments?
Over 4 years (2020 to 2025), Biogen's unrealized gains on investments has grown at a -45.7% compound annual growth rate (CAGR), from $2.30M to $200.00K.
What does unrealized gains on investments mean?
The total profit on investments that the company owns but has not yet sold.